| Financial Year |
March 31 2023 |
| Monetary Funds |
2,059,991,311.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,843,604.43 |
| Accounts Receivable |
7,068,624,423.35 |
| Advances to Suppliers |
252,234,314.56 |
| Other Receivables |
269,896,616.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,536,610,757.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
108,411,303.48 |
| Total Current Assets |
13,536,066,955.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,612,715.56 |
| Investment Properties |
166,487,456.77 |
| Fixed Assetes |
755,544,433.48 |
| Under-construction Projects |
94,012,539.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
145,948,701.90 |
| R&D expenses |
-- |
| Goodwill |
158,182,646.52 |
| Long-Term Deferred and Prepaid Expenses |
37,970,789.61 |
| Deferred Income Tax Assets |
29,248,365.22 |
| Other Non-Current Assets |
818,843.76 |
| Sub-Total of Non-Current Assets |
1,539,467,130.67 |
| Total Assets |
15,075,534,086.42 |
| Short-Term Loans |
3,505,269,337.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,208,019,160.93 |
| Accounts Payable |
4,258,484,079.17 |
| Accounts Received In Advance |
87,467.85 |
| Employee Compensation Payable |
195,333,449.75 |
| Taxes Payable |
97,939,352.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
516,819,612.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
349,110,670.73 |
| Other Current Liabilities |
13,150,653.09 |
| Sub-Total of Current Liabilities |
10,251,235,291.50 |
| Long-term Loans |
3,000,000.00 |
| Bonds Payable |
512,250,566.02 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,139,248.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
667,870,008.53 |
| Total Liabilities |
10,919,105,300.03 |
| Paid-In Capital(Or Share Stock) |
505,445,173.00 |
| Capital Surplus |
1,816,601,482.64 |
| Surplus Reserve |
38,181,333.19 |
| LESS:Treasury Stock |
43,502,400.00 |
| Undistributed Profits |
1,304,584,331.56 |
| Minority Stockholder's Interest |
430,981,915.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,725,446,871.36 |
| Owner's Equity（Stockholder's Equity） |
4,156,428,786.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,075,534,086.42 |
